Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	38.83	39.55	42.01	35.99	37.44	34.39
Revenue Growth (YoY)	-3.08%	-5.85%	16.75%	-3.89%	8.88%	17.19%
Cost of Revenue	6.39	6.07	9.12	8.81	8.65	7.42
Gross Profit	32.43	33.49	32.89	27.17	28.79	26.97
Selling, General & Admin	28.85	29.1	26.84	24.8	24.96	25.25
Research & Development	5.49	5.83	6.69	5.68	5.77	6.87
Other Operating Expenses	7.98	8.1	5.07	4.37	4.43	4.13
Operating Expenses	42.33	43.04	38.6	34.85	35.17	36.26
Operating Income	-9.89	-9.55	-5.7	-7.68	-6.38	-9.29
Interest Expense / Income	0.6	0.67	0.59	0.1	0.26	0.25
Other Expense / Income	-2.12	-3.99	-0.79	-4.3	-3.36	-5.92
Pretax Income	-8.37	-6.23	-5.5	-3.47	-3.28	-3.62
Income Tax	0.05	0.05	0.07	0.03	0.06	-0.08
Net Income	-8.42	-6.28	-5.57	-3.51	-3.34	-3.54
Shares Outstanding (Basic)	14	14	15	15	15	15
Shares Outstanding (Diluted)	14	14	15	15	15	15
Shares Change	-3.36%	-1.82%	-2.29%	-1.70%	-1.52%	-1.40%
EPS (Basic)	-0.59	-0.44	-0.38	-0.24	-0.22	-0.23
EPS (Diluted)	-0.59	-0.44	-0.38	-0.24	-0.22	-0.23
Free Cash Flow	5.04	5.64	6.38	5.99	3.3	2.04
Free Cash Flow Per Share	0.36	0.39	0.44	0.40	0.22	0.13
Gross Margin	83.54%	84.66%	78.29%	75.51%	76.89%	78.42%
Operating Margin	-25.48%	-24.16%	-13.58%	-21.34%	-17.04%	-27.01%
Profit Margin	-21.68%	-15.88%	-13.26%	-9.75%	-8.92%	-10.29%
Free Cash Flow Margin	12.98%	14.26%	15.19%	16.64%	8.82%	5.92%
EBITDA	-1.82	0.2	0.41	1.23	1.73	1.03
EBITDA Margin	-4.68%	0.52%	0.98%	3.42%	4.62%	3.00%
Depreciation & Amortization	5.95	5.77	5.33	4.61	4.75	4.4
EBIT	-7.77	-5.57	-4.92	-3.37	-3.02	-3.37
EBIT Margin	-20.01%	-14.07%	-11.70%	-9.38%	-8.07%	-9.80%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).